Compare Nuwellis Inc (NUWE) vs ProShares UltraPro S&P500 (UPRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs ProShares UltraPro S&P500 — how do they compare? Nuwellis Inc trades at $2.95 (market cap $1.09M), while ProShares UltraPro S&P500 trades at $141.66. The key difference: ProShares UltraPro S&P500 is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | UPRO | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $527.46 | $150.93 |
52-Week Low | $2.80 | $89.29 |
Enterprise Value | -$722.58K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About ProShares UltraPro S&P500
UPRO is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the S&P 500 Index. It is a tactical, high-conviction instrument designed for short-term traders to amplify bullish market moves, utilizing a daily reset mechanism that creates significant compounding effects and volatility risks over time.
Read more on UPRO →
